Kyoung Il Min

1 Introduction T-cell lymphoblastic lymphoma (T-LBL) is a rare non-Hodgkin lymphoma that accounts for approximately 2% of patients who undergo a neoplastic transition from immature precursor T cells [1]. The World Health Organization defines T-LBL and T-cell acute lymphoblastic leukemia (T-ALL) as the same entity. T-LBL and T-ALL share similar genomic changes in early thymocyte subsets [2, 3]. Recent efforts have been made to distinguish T-LBL from T-ALL because of the different clinical features.

Correction to: Nature Communications https://doi.org/10.1038/s41467-022-29925-x, published online 25 April 2022. The original version of the Supplementary Information associated with this Article included an incorrect Supplementary Data 1 file, which was an incorrect version of the Source Data. The original Source Data file is correct. The HTML has been updated to remove Supplementary Data 1. Author information Author notes These authors contributed equally: Jimyung Seo, HyunSeok Kim.